ரோச் பிரான்ஸ் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ரோச் பிரான்ஸ். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ரோச் பிரான்ஸ் Today - Breaking & Trending Today

Acticor Biotech Announces Appointment of Mr Alain Munoz as Chairman of the Board of Directors and Mrs Sophie Binay and Mr Yannick Pletan as General Managers

Acticor Biotech Announces Appointment of Mr Alain Munoz as Chairman of the Board of Directors and Mrs Sophie Binay and Mr Yannick Pletan as General Managers
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

France General , Pierre Fabre , Martine Jandrot Perrus , Gilles Avenard , Yannick Pletan , Bioalliance Pharma , Annie Florence Loyer , Amryt Pharma , Zealand Pharma , Alain Munoz , Newton Biocapital , Kostenloser Wertpapierhandel , Sophie Binay , Sanofi Group , Gustave Roussy Cancer Center , Early Clinical Development , Auris Medical Holding , Scientific Committee Of The French , Sud University , Scientific Division , Foundation At Roche France , Primer Capital Armesa Foundation , Foundation At Pfizer , Acticor Biotech , Mrs Sophie Binay , Acute Ischemic Stroke ,

Moderna Provides Business Update and Announces Three New Development Programs in Infectious Disease Vaccines

Published: Jan 11, 2021
CAMBRIDGE, Mass. (BUSINESS WIRE) Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that it is expanding its pipeline of innovative vaccines with three new development programs based on the clinical success of its infectious disease vaccine portfolio to date. This announcement reflects the Company’s commitment to accelerating its infectious disease portfolio based on Moderna’s experience with its COVID-19 vaccine. The development programs announced today are mRNA vaccine candidates against seasonal flu, HIV and the Nipah virus. Moderna also announced an expansion of its respiratory syncytial virus (RSV) vaccine program into older adults. ....

United States , United Kingdom , Intratumoral Immuno , Corinne Le Goff , Le Goff , Ruchira Glaser , Head Of Clinical Sciences For The , Melinda Gates Foundation , Moderna New Infectious Disease Vaccine Development Programs , European Union , Vaccine Research Center , Us Department Of Health , National Institutes Of Health , Human Services , Drug Administration , Development Authority , Public Health Vaccines , Vaccine Initiative , Exchange Commission , Us Biomedical Advanced Research , Society For Immunotherapy Of Cancer Annual Meeting , Roche Group , Office Of The , University Of Pennsylvania , Summary Of Program Updates , Us Business Organization At Amgen Nasdaq ,